The MELODY Trial Is Now Recruiting Pregnant Women with Ulcerative Colitis

The MELODY Trial, a trial that tests the hypothesis that a non-invasive dietary intervention during the last trimester of pregnancy could beneficially shift the microbiome of patients with Crohn's disease and their babies, promoting a healthier immune system during a critical time of the immune system development, has expanded and is now recruiting pregnant women with ulcerative colitis. Incentives for participating in the trial have also increased.